These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 12750167)
1. BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Baldus CD; Tanner SM; Ruppert AS; Whitman SP; Archer KJ; Marcucci G; Caligiuri MA; Carroll AJ; Vardiman JW; Powell BL; Allen SL; Moore JO; Larson RA; Kolitz JE; de la Chapelle A; Bloomfield CD Blood; 2003 Sep; 102(5):1613-8. PubMed ID: 12750167 [TBL] [Abstract][Full Text] [Related]
2. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. Baldus CD; Thiede C; Soucek S; Bloomfield CD; Thiel E; Ehninger G J Clin Oncol; 2006 Feb; 24(5):790-7. PubMed ID: 16418499 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype. El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678 [TBL] [Abstract][Full Text] [Related]
4. BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Schwind S; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Becker H; Whitman SP; Wu YZ; Metzeler KH; Powell BL; Kolitz JE; Carter TH; Moore JO; Baer MR; Carroll AJ; Caligiuri MA; Larson RA; Bloomfield CD Blood; 2010 Dec; 116(25):5660-9. PubMed ID: 20841507 [TBL] [Abstract][Full Text] [Related]
5. BAALC and ERG expression in acute myeloid leukemia with normal karyotype: impact on prognosis. Eid MA; Attia M; Abdou S; El-Shazly SF; Elahwal L; Farrag W; Mahmoud L Int J Lab Hematol; 2010 Apr; 32(2):197-205. PubMed ID: 19555438 [TBL] [Abstract][Full Text] [Related]
6. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041 [TBL] [Abstract][Full Text] [Related]
7. Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia. Hasan SK; Patkar NV; Rajamanickam D; Gokarn A; Lucena-Araujo AR; Tembhare P; Bagal B; Kadam Amare P; Jain H; Gujral S; Sengar M; Subramanian PG; Khattry N Hematol Oncol; 2020 Dec; 38(5):808-816. PubMed ID: 32893896 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. Marcucci G; Baldus CD; Ruppert AS; Radmacher MD; Mrózek K; Whitman SP; Kolitz JE; Edwards CG; Vardiman JW; Powell BL; Baer MR; Moore JO; Perrotti D; Caligiuri MA; Carroll AJ; Larson RA; de la Chapelle A; Bloomfield CD J Clin Oncol; 2005 Dec; 23(36):9234-42. PubMed ID: 16275934 [TBL] [Abstract][Full Text] [Related]
9. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia. Xiang L; Li M; Liu Y; Cen J; Chen Z; Zhen X; Xie X; Cao X; Gu W Ann Hematol; 2013 Aug; 92(8):1063-9. PubMed ID: 23515710 [TBL] [Abstract][Full Text] [Related]
10. The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia. Aref S; Al Khodary T; Zeed TA; El Sadiek A; El Menshawy N; Al Ashery R Indian J Hematol Blood Transfus; 2015 Mar; 31(1):21-8. PubMed ID: 25548440 [TBL] [Abstract][Full Text] [Related]
11. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Byrd JC; Mrózek K; Dodge RK; Carroll AJ; Edwards CG; Arthur DC; Pettenati MJ; Patil SR; Rao KW; Watson MS; Koduru PR; Moore JO; Stone RM; Mayer RJ; Feldman EJ; Davey FR; Schiffer CA; Larson RA; Bloomfield CD; Blood; 2002 Dec; 100(13):4325-36. PubMed ID: 12393746 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML. Jentzsch M; Bill M; Grimm J; Brauer D; Backhaus D; Goldmann K; Schulz J; Niederwieser D; Platzbecker U; Schwind S Ann Hematol; 2020 Oct; 99(10):2417-2427. PubMed ID: 32862286 [TBL] [Abstract][Full Text] [Related]
13. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374 [TBL] [Abstract][Full Text] [Related]
15. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Langer C; Radmacher MD; Ruppert AS; Whitman SP; Paschka P; Mrózek K; Baldus CD; Vukosavljevic T; Liu CG; Ross ME; Powell BL; de la Chapelle A; Kolitz JE; Larson RA; Marcucci G; Bloomfield CD; Blood; 2008 Jun; 111(11):5371-9. PubMed ID: 18378853 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. Visani G; Bernasconi P; Boni M; Castoldi GL; Ciolli S; Clavio M; Cox MC; Cuneo A; Del Poeta G; Dini D; Falzetti D; Fanin R; Gobbi M; Isidori A; Leoni F; Liso V; Malagola M; Martinelli G; Mecucci C; Piccaluga PP; Petti MC; Rondelli R; Russo D; Sessarego M; Specchia G; Testoni N; Torelli G; Mandelli F; Tura S Leukemia; 2001 Jun; 15(6):903-9. PubMed ID: 11417475 [TBL] [Abstract][Full Text] [Related]
17. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. Farag SS; Ruppert AS; Mrózek K; Mayer RJ; Stone RM; Carroll AJ; Powell BL; Moore JO; Pettenati MJ; Koduru PR; Stamberg J; Baer MR; Block AW; Vardiman JW; Kolitz JE; Schiffer CA; Larson RA; Bloomfield CD J Clin Oncol; 2005 Jan; 23(3):482-93. PubMed ID: 15534356 [TBL] [Abstract][Full Text] [Related]
18. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD; J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018 [TBL] [Abstract][Full Text] [Related]
19. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients. Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853 [TBL] [Abstract][Full Text] [Related]
20. Gene expression of BAALC, CDKN1B, ERG, and MN1 adds independent prognostic information to cytogenetics and molecular mutations in adult acute myeloid leukemia. Haferlach C; Kern W; Schindela S; Kohlmann A; Alpermann T; Schnittger S; Haferlach T Genes Chromosomes Cancer; 2012 Mar; 51(3):257-65. PubMed ID: 22072540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]